Alfaro, Rosalie D.

HRN: 01-08-46  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/10/2024
CEFTRIAXONE 1G (VIAL)
09/10/2024
09/17/2024
IV
1g
Q12
Spondylosis Disk Dessication L4- L5
Waiting Final Action 
09/19/2024
CO-AMOXICLAV 625MG (TAB)
09/19/2024
09/26/2024
ORAL
625mg/tab
1 Tab Every 8 Hours
Herniated Nucleus Pulposus
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: